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West Nile virus (WNV) and dengue virus (DENV) are highly pathogenic, mosquito-borne flaviviruses (family Flaviviridae) that
cause severe disease and death in humans. WNV and DENV actively replicate in mosquitoes and human hosts and thus encoun-
ter different host immune responses. RNA interference (RNAi) is the predominant antiviral response against invading RNA vi-
ruses in insects and plants. As a countermeasure, plant and insect RNA viruses encode RNA silencing suppressor (RSS) proteins
to block the generation/activity of small interfering RNA (siRNA). Enhanced flavivirus replication in mosquitoes depleted for
RNAi factors suggests an important biological role for RNAi in restricting virus replication, but it has remained unclear whether
or not flaviviruses counteract RNAi via expression of an RSS. First, we established that flaviviral RNA replication suppressed
siRNA-induced gene silencing inWNV and DENV replicon-expressing cells. Next, we showed that none of theWNV encoded
proteins displayed RSS activity in mammalian and insect cells and in plants by using robust RNAi suppressor assays. In contrast,
we found that the 3=-untranslated region-derived RNAmolecule known as subgenomic flavivirus RNA (sfRNA) efficiently sup-
pressed siRNA- andmiRNA-induced RNAi pathways in both mammalian and insect cells. We also showed thatWNV sfRNA in-
hibits in vitro cleavage of double-stranded RNA by Dicer. The results of the present study suggest a novel role for sfRNA, i.e., as a
nucleic acid-based regulator of RNAi pathways, a strategy that may be conserved among flaviviruses.
Arthropod-borne (arbo)viruses form a diverse group of medi-cally important viruses, many of which are emerging patho-
gens (72). Arboviruses take a unique position within the viro-
sphere by displaying active replication in both vertebrate hosts
(humans, other mammals, and birds) and invertebrate vectors
(e.g., mosquitoes, ticks, midges, and sandflies) (41). Upon infec-
tion of mosquitoes, the virus persistently replicates in multiple
tissues of the insect, andhigh virus titers accumulate in the salivary
glands by the end of this so-called extrinsic incubation time, typ-
ically 1 to 2 weeks. Since the virus needs the vector for successful
infection of the vertebrate hosts to complete the transmission cy-
cle, evolutionary pressure has likely caused the virus to be only
mildly or nonpathogenic to the arthropod host (17). Nonetheless,
to perpetuate the viral life cycle involving invertebrate vector and
vertebrate host, the virus must be sufficiently equipped to cross
the initial midgut infection barrier in the vector and must be able
to disseminate within the arthropod to eventually accumulate
progeny virus in the salivary glands.
Mosquitoes and other arthropods have an array of mecha-
nisms to fight microbial and viral infections. RNA-induced gene
silencing or RNA interference (RNAi) is the key component of the
insect innate immune system to limit a diverse range of RNA
viruses, including flaviviruses (6, 55), while the Toll, IMD, and
JAK-STAT pathways also contribute to control flavivirus infec-
tion in mosquitoes (17). As a countermeasure, insect-specific vi-
ruses have been demonstrated to suppress this antiviral RNAi re-
sponse by producing specialized proteins that obstruct one or
more of the key RNAi components.Well-studied examples are the
FlockHouse virus (FHV)B2 viral RNA silencing suppressor (RSS)
(37), the Cricket paralysis virus (CrPV) 1A RSS (44, 71), and the
relatedDrosophilaCvirus (DCV) 1A protein (65). For FHV, it was
shown that suppression of antiviral RNAi by expression of a viral
RSS was crucial for establishing efficient viral replication and vi-
rion production (31).
Until now, no viral RSS have conclusively been identified in
arboviral genomes. For dengue virus (DENV), it was suggested
from preliminary experiments that none of the DENV mature
viral proteins could suppress RNAi (32). More recently, it was
hypothesized that arbovirusesmay not even need a RSS, since they
subject themselves to antiviral RNAi and replicate at lower levels
to establish persistent infection of the insect host (64). While it
remains to be seen whether this is true for all arboviruses without
exception, persistent virus infection of the arthropod—the hall-
mark of arbovirus replication—does not inevitably mean that the
virus does not display RSS activity. For example, the insect-spe-
cific viruses DCV, CrPV, and FHV all encode strong RSSs in their
genomes (44, 65, 71), and yet all of these viruses can persistently
infect their insect hosts. Conversely, it can be hypothesized that
persistently infecting arboviruses may encode RSSs, for example, to
allowsufficient levelsof viral replication invector insects, especially in
view of the high potency of the antiviral RNAi response (6).
West Nile virus (WNV) and DENV are highly pathogenic,
mosquito-borne viruses (family Flaviviridae, genus Flavivirus)
that cause severe disease and death in humans (34). Flavivirus
virions contain a single copy of the viral genome, which encodes a
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polyprotein that is proteolytically cleaved into seven nonstruc-
tural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5)
and three structural proteins (C, prM, and E). The positive-
stranded RNA genome of11 kb is flanked by 5= and 3= untrans-
lated regions (UTRs), which play essential roles in initiation of
translation andRNA replication (40). Interestingly, recent reports
have demonstrated thatmany,most likely all, flaviviruses produce
a second, subgenomic flavivirus RNA (sfRNA), which accumu-
lates to high levels in a diverse range of infected mammalian and
insect cells (33, 52, 56). sfRNA is a positive-sense, noncoding RNA
molecule representing the last 525 nucleotides (nt) (in the case of
WNV) of the viral genomic RNA that is generated as the result of
incomplete degradation of genomic RNA by the cellular exoribo-
nuclease XRN1 in cytoplasmic processing bodies (PBs) (19, 52,
60). PBs are cytoplasmic granules functional in mRNA degrada-
tion, mRNA surveillance and translational repression. The RNAi
machinery is also concentrated in PBs (16). It has been shown that
sfRNA production is required for viral pathogenicity in a mam-
malian animal model, although its exact mode of action remains
to be uncovered (52). Recent studies suggest that sfRNA plays a
role in inhibiting the alpha/beta interferon (IFN-/) response in
mice (59) and alsomay serve as themain source ofWNV-encoded
miRNA in mosquito cells (25).
According to the arbovirus definition, flaviviruses actively rep-
licate in both the invertebrate vector and the vertebrate host and
thus encounter an array of different host immune responses, in-
cluding RNAi during virus replication in mosquitoes (17). By de-
pleting crucial insect RNAi factors it became clear that RNAi is
very efficient in limiting flavivirus replication in insects (10, 55).
However, it remains to be uncovered how exactly flaviviruses
evade and/or suppress the antiviral RNAi response.
Here we have studied the interaction betweenWNV and RNAi
in different model systems. We have screened the various WNV
products, including viral proteins and sfRNA, for activity as RNAi
suppressor in different RNAi suppressor assays. We show that
sfRNA but not viral proteins display RNAi suppressor activity in
insect and mammalian cells. Finally, we provide evidence using
DENV that this novel role of sfRNA is characteristic for flavivi-
ruses.
MATERIALS AND METHODS
Plasmids. The mammalian expression plasmids pGL3 and pRL-CMV
(Promega), the short hairpin-encoding plasmid Firefly luciferase (pShh1-
Ff1) (48), or the nonspecific pEF-MBP, pEF-MBP-NS3, were as previ-
ously described (57). The 3=UTRs of WNV and DENV and MBP-HDVr
were cloned into the mammalian expression vector pcDNA-DEST40 (In-
vitrogen) downstream of the cytomegalovirus (CMV) promoter using
Gateway technology. The pAdvantage construct expressing adenovirus
VA RNAI/II was purchased from Promega. The miRNA-based sensor
constructs pCMV-Fluc-miRNA30-AP, pCMV-Fluc-random, pCMV-
hsa-miRNA30, and pCMV-hsa-miRNA21 have been described previ-
ously (77). The selectable WNV and DENV replicons have been previ-
ously described (35, 53, 54). The insect expression vectors encoding
MBP-HDVr, the DENV 3=UTR, and the WNV 3=UTR either fused to
MBP or alone were cloned behind the baculovirus OpIE2 promoter into
the pIB-GW (58) vector using Gateway technology. The expression vec-
tors encoding either MBP or Cymbidium ringspot virus (CymRSV) P19
have been described previously, as well as the inducible insect miRNA-
based sensor constructs, pMT-FF-3=UTR, pMT-pri-dme-miRNA1, and
pMT-pri-dme-miRNA-12 (58) and the inducible Firefly and Renilla lu-
ciferase constructs (65), all expressed via the Drosophila metallothionein
gene promoter. Insect expression vectors encoding short hairpin RNA
were constructed by annealing previously described DNA oligonucleo-
tides (69) either against Firefly luciferase or enhanced green fluorescent
protein (eGFP) and cloning these as KpnI-XbaI fragments in pMT-B (In-
vitrogen) behind the Drosophila metallothionein gene promoter. For the
RNA silencing experiments in U4.4 cells, Firefly and Renilla luciferase
constructs were used, which have previously been described (46) and are
expressed via the OpIE2 or AcIE1 promoters, respectively.
To check the functionality of the WNV miRNA sensor constructs
(described in reference 25 and now recloned in pGL3 [Promega] for
expression in mammalian cells), pSuper plasmids expressing small
interfering RNA (siRNA) from the H1 RNA polymerase III promoter
were constructed (8). The following complementary oligonucleotides
with (partial) restriction sites (indicated in boldface) and complemen-
tary regions (underlined) were designed according to methods pub-
lished onlinebyOligoEngineandwere cloned in theBglII andHindIII sitesof
pSuper: pSUPER-A1A2-F, GATCCCCGCTCTGCACAACCA
GCCACACGGCACTTCAAGAGAGTGCCGTGTGGCTGGTTGTGCA
GAGCTTTTTA; pSUPER-A1A2-R, AGCTTAAAAAGCTCTGCACAAC
CAGCCACACGGCACTCTCTTGAAGTGCCGTGTGGCTGGTTGTGC
AGAGCGGG; pSUPER-C1C2-F, GATCCCCGACAATGGTGGCTGGT
GGTGCGAGAATTCAAGAGATTCTCGCACCACCAGCCACCATTGT
CTTTTTA; and pSUPER-C1C2-R,AGCTTAAAAAGACAATGGTGGCT
GGTGGTGCGAGAATCTCTTGAATTCTCGCACCACCAGCCACCAT
TGTCGGG. Plasmid pSuper-A1A2 expresses a short hairpin consisting of
A1A2, a short loop region and the reverse complement sequence A1A2rc.
Upon expression in mammalian cells, this plasmid expresses siRNA that
will silence transcripts containing both A1A2 or A1A2rc sequences. Sim-
ilarly, pSuper-C1C2 targets C1C2 or C1C2rc containing transcripts.
Cell culture and transfection.African greenmonkey kidneyVero and
baby hamster kidney BHK-21 cells were grown as a monolayer in Dul-
beccomodified Eaglemedium (Gibco/BRL) supplementedwith 10% fetal
calf serum (FCS; Gibco), streptomycin (100 g/ml), and penicillin (100
U/ml) at 37°C and 5%CO2. To reach a confluence of 60 to 70%at the time
of transfection, the cells were trypsinized 24 h pretransfection and seeded
in 24-well plates at a concentration of 1.1  105 cells per well. Transfec-
tions were performed using JetPei according to the manufacturer’s in-
structions. To create stable mammalian replicon cell lines, Vero cells were
transfected with capped, in vitro-transcribed replicon RNA, using Lipo-
fectamine2000 (Invitrogen) according to themanufacturer’s instructions.
At 24 h posttransfection (hpt), transfected cells were selected with puro-
mycin (WNV replicon [36, 53]) or G418 (DENV replicon [54]). For the
transient RNA silencing suppressor assays using short hairpin constructs
as inducer molecules, (replicon) cells were transfected with luciferase ex-
pression plasmids, i.e., 100 ng of Firefly luciferase (pGL3; Promega), 2 ng
of Renilla luciferase (pRL-CMV; Promega), and 4 ng of short hairpin
encoding plasmids, either nonspecific or Firefly luciferase specific
(pShh1-Ff1 [48]). In the case of transient expression of the RNA silencing
suppressor, the cells were also cotransfected with the corresponding ex-
pression plasmid (MBP, MBP-NS3, MBP-NS3mutant, MBP-HDVr,
WNV sfRNA, or DENV sfRNA).
The miRNA-based sensor experiments were performed in a similar
way as previously described for the shRNA-induced silencing experi-
ments. Briefly, cells were seeded in 24-well plates and cotransfected with
200 ng of sensor construct (pCMV-FF-miRNA30-AP or pCMV-FF-ran-
dom [77]), 2 ng of Renilla luciferase plasmid (pRL-CMV; Promega), and
10 ng of pri-miRNA expression plasmid vectors expressing either human
pri-hsa-miRNA21or pri-hsa-miRNA30 (77). All cells were lysed at 48 hpt,
and the luciferase activity was determined using a dual luciferase reporter
assay (15).
Drosophila melanogaster Schneider-2 (S2) cells were grown in Sch-
neider’s medium (Invitrogen) supplemented with 10% heat-inactivated
FCS (Gibco) at 28°C. The cells were seeded 24 h pretransfection in a
96-well plate at a concentration of 5  104 cells per well. Transfections
were performed using Cellfectin II (Invitrogen) according to the manu-
facturer’s instructions. For the shRNA suppressor assays, the S2 cells were
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cotransfected with luciferase-expressing plasmids (15 ng of pMT-Fluc
and 6 ng of pMT-Rluc) and 50 ng of short hairpin-expressing vectors,
either Fluc specific or nonspecific. The cells were also cotransfected with
100 ng of the RNA silencing suppressor expressing plasmid (MBP, Rice
Hoja Blanca virus [RHBV] NS3, or WNV sfRNA). For the miRNA-based
suppressor assays, the S2 cells were cotransfected with 100 ng (unless
stated otherwise) of RNA silencing suppressor expression plasmid (MBP,
Carnation Italian ringspot virus [CIRV] P19, or WNV sfRNA), 12.5 ng of
pMT-Fluc-3=UTR, 3 ng of pMT-Rluc, and 2.5 ng of pMT-miRNA (either
pri-dme-miRNA1 or pri-dme-miRNA12). Expression of the inducible
constructs was induced 48 hpt by 5 M CuSO4 and assayed 24 h postin-
duction.
Aedes albopictusU4.4 and Aedes pseudoscutellaris Ap61 mosquito cells
were grown in Leibovitz L-15 medium (Invitrogen) supplemented with
10% heatinactivated FCS (Gibco), 2% tryptose phosphate broth (Sigma),
and 1% nonessential amino acids (Invitrogen) at 28°C. Then, 1.5  105
cells were seeded per well in a 24-well plate. Transfections were performed
24 h after seeding using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. For the double-stranded RNA (dsRNA)-in-
duced silencing assay, 8 ng of pAcIE1-Renilla, 50 ng of pIZ-Firefly, and
500 ng of the different pIB-vectors (MBP, MBP-HDVr, 3=UTRWNV, or
3=UTR DENV) were cotransfected in U4.4 cells. Silencing was induced
after 24 h by transfection of 1.8 ng of dsRNA, using either Firefly lu-
ciferase-specific (dsFluc) or off-target (ds-scrambled) constructs. The
cells were lysed 24 h after dsRNA transfection, and the luciferase expres-
sion was determined using a dual luciferase reporter assay (15).
The siRNA-induced silencing assay was performed as previously de-
scribed (57). Briefly, Vero cells were seeded and transfected 24 h later with
constructs expressing the sfRNA constructs, tombusvirus P19, or MBP-
HDVr as a negative control. At 24 hpt, and the cells were cotransfected
with specific (siFluc) or nonspecific siRNA (si-scrambled) molecules and
constructs expressing Firefly luciferase and Renilla luciferase. The cells
were lysed, and the luciferase expression was determined 48 h after the
second transfection.
SFV replicons. SFV replicons were constructed as follows. The WNV
3=UTR-HDVr was PCR amplified from the existing insect expression
plasmid (pIB-3=UTR WNV-HDVr) to introduce BamHI and XmaI sites
for cloning behind the subgenomic 26S promoter of SFV-3H-Rluc repli-
con, resulting in SFV-3H-Rluc-3=UTR WNV. The SFV1-3H-Rluc repli-
con was generated by replacement of the BglII-SpeI restriction fragment
frompSFV4-3H-Rluc (28) with the corresponding fragment frompSFV1.
SFV-3H-Rluc-ECMV IRESwas constructed in a similar way using BamHI
and XmaI sites. SFV-3H-Rluc replicons were linearized by SpeI and in
vitro transcribed by using a SP6MEGAscript kit (Ambion) in the presence
of cap analogue according to the manufacturer’s protocol. In vitro-tran-
scribed RNA was transfected in U4.4 cells 24 h after seeding in a 24-well
plate (1.5 105 cells/well). Luciferase expression was measured at 24 hpt
using a Renilla luciferase assay.
Statistics. The relative luciferase expression (RL) was calculated as
RLi IFluc,i/IRluc,i, where I is themeasured intensity and i is the sample. To
cancel out construct-specific effects, values under treatment (for example,
cotransfection with shFluc) were normalized against the same construct
that was treated with a negative control (in this example, sh-scrambled).
Thus, NRLx RLi,treated/RLi,negative control.
Experiments were performed in duplicate or in triplicate and repeated
independently at least twice. The independent experiments were averaged
as follows:
NRL
—
 
x
n NRLx
n
where x is the xth experiment and n is the total number of experiments.
The statistics were calculated using custom written scripts in R (www.r
-project.org). In the case of pairwise testing a two-sample independent t
test was performed, as provided by R.Multiple testing was done by apply-
ing Tukey’s honestly significant difference test (Tukey’s HSD; also known
as Tukey’s range test), and the q-valuewas calculated and compared to the
indexed q-value in the studentized range distribution available in R. Sig-
nificant differences (P 0.05) are indicated in the figures by asterisks.
dsRNA production and electromobility shift assays (EMSAs). Ra-
dioactively labeled 114-nt dsRNA, siRNA, and miRNA molecules were
produced as previously described (58). Briefly, the 114-nt dsRNA was
generated by T7 RNA polymerase (Promega) transcription from an eGFP
PCR product in the presence of [-32P]CTP (Perkin-Elmer), followed by
incubation at 70°C for 10 min and cooling down slowly. After treatment
with DNase I and RNase A, dsRNA molecules were loaded onto an 8%
PAGE–0.5 Tris-borate-EDTA (TBE) native gel and gel purified. siRNA
and miRNA molecules were produced by end labeling of the GFP siRNA
guide strand or the ath-miRNA171a strand using [-32P]ATP (Perkin-
Elmer) and T4 polynucleotide kinase, followed by gel purification (22).
The binding reaction was performed as previously described (24, 58). A
total of 0.5 nM radiolabeled RNA was incubated for 20 min at room
temperature with2g of total protein from the cell extract. Complexes
were separated on a native 0.5TBE acrylamide gel, either a 5% gel in the
case of 114-nt dsRNA or an 8% gel for small dsRNAs, and then visualized
by exposure to a phosphorimager screen overnight.
Ago1/2 depletion in insect cells. Templates for dsRNA production of
Drosophila melanogaster Ago1 and Ago2 were produced by PCR using
primers with T7 promoter sequences (Ago1 FW, TAATACGACTCACTA
TAGGGAGAGTTCCG TTACCTGAAGATCACC; Ago1 RV, TAATACG
ACTCACTATAGGGAGAAGAAGAGTCGAGTGTGATGGC; Ago2 FW,
TAATACGACTCACTATAGGGAGATACTATGGTGAAGAACGGG
TCG; and Ago2 RV, TAATACGACTCACTATAGGGAGAGAACATGTC
CTCAATCTCCTCC). PCR products were gel purified and used for
dsRNA production with the RNAi MEGAscript kit (Ambion). Experi-
ments investigating the effect of Ago1 or Ago2 knockdown on the miR1
sensor constructs in S2 cells were basically performed as previously de-
scribed (58). S2 cells were mixed with 200 ng of dsRNA of either Ago1,
Ago2, or eGFP (unspecific) during seeding. Transfectionswere performed
using Lipofectamine 2000 (Invitrogen) as described by the manufacturer.
Knockdown efficiencies were checked by reverse transcription-PCR (RT-
PCR) using the above primers andWestern blot analysis using antibodies
against Ago1/2 (Abcam, ab5070 and ab5072).
In vitroDicer assay. dsRNAof 700 bp of theGFP genewas transcribed
in vitro as described previously (58) using T7 RNA polymerase (Invitro-
gen). dsRNA was digested into siRNA by recombinant human Dicer
(Genlantis), either in the absence or in the presence of decreasing
amounts of in vitro-transcribed WNV sfRNA (52). Reactions products
were loaded on an RNase-free agarose gel and stained with ethidium bro-
mide.
Immunofluorescence and Beta-galactosidase staining. WNVrep
cells expressing -galactosidase were visualized using X-Gal (5-bromo-4-
chloro-3-indolyl--D-galactopyranoside) staining. After being washed
with phosphate-buffered saline (PBS), the cells were fixed for 10min with
4% paraformaldehyde, followed by washing with PBS and the addition of
X-Gal solution (53). The cells were incubated at 37°C, and blue cells were
visualized by microscopy. Maintenance of viral replication in DENVrep
cells was determined by immunofluorescence using a J2 monoclonal an-
tibody that specifically recognizes long dsRNA and a rhodamine anti-
mouse secondary antibody (Molecular Probes). Detection was performed
as previously described (18).
RESULTS
WNV RNA replication impairs RNA silencing in mammalian
cells. To investigate whether West Nile virus (WNV) RNA repli-
cation had any effect on the efficiency of RNAi in mammalian
cells, shRNA-induced silencing assays were performed in either
wild-type Vero cells or Vero cells stably expressing a WNV repli-
con. Stable WNV replicon cells were established by transfecting
Vero cells with in vitro-transcribed WNV replicon RNA express-
ing -galactosidase as the reporter protein (Fig. 1A), followed by
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puromycin selection (36, 53). X-Gal staining of puromycin-resis-
tant WNV replicon cells, with nontransfected Vero cells as the
negative control, confirmed a successful selection procedure (Fig.
1B). Vero cells with or without WNV replicon were transfected
with plasmids encoding Firefly luciferase as the reporter, Renilla
luciferase as internal transfection control, and a plasmid express-
ing either a shRNA against firefly luciferase (shFluc) or off-target
(sh-scrambled) (57). The sequence-specific silencing of Fluc by
shFluc was significantly less efficient in WNV replicon cells com-
pared to silencing in normal Vero cells, with 22% versus 10%
relative luciferase activity, respectively (Fig. 1C). These results
show that WNV RNA replication has a negative effect on the effi-
ciency of shRNA-induced RNA silencing in mammalian cells.
WNVnonstructural proteins donot suppress RNAi inmam-
malian cells or in plants. Interference with the (antiviral) RNA
silencing machinery is a common feature of plant and insect vi-
ruses, which encode specialized proteins called RNA silencing
suppressors (RSSs). Even in some mammalian viruses, proteins
have been reported with apparent RSS activity, e.g., NS1 of influ-
enza A virus or Ebola virus VP35 (9, 21, 63). Themajority of these
RSSs act by binding to dsRNA, which are key molecules in the
mammalian IFN response but also in the RNA silencing pathways
(13).
In order to find an explanation for the observed reduced effi-
ciency of RNAi in flavivirus replicon cells (Fig. 1B), we examined
whether any of the WNV products, i.e., nonstructural proteins
and/or sfRNA, could act in a fashion similar to other RSS proteins
by binding dsRNA molecules.
First, in an EMSA, cell extracts of Vero or Vero-WNVrep cells
weremixed with either radiolabeled siRNA or long 114-nt dsRNA
molecules and loaded onto native acrylamide gels (Fig. 2). No
retardation could be observed for any of the investigated extracts,
in contrast to the positive controls, RHBV-NS3 (binding exclu-
sively siRNA [24]) (Fig. 2A, left) and influenza virus NS1 (binding
long dsRNA [70]) (Fig. 2A, right). To rule out putative cell line-
specific differences, WNV replicon cell lines were also established
in mosquito (Ap61) and rodent (BHK-21) cells, and cell extracts
were tested in a similar EMSA (Fig. 2B). Again, no retardation of
si/miRNA (Fig. 2B, left) or long dsRNA (Fig. 2B, right) could be
observed for any of the investigated extracts. Together, these re-
sults suggest that none of the nonstructural proteins of WNV was
able to efficiently bind small or longer dsRNA molecules in this
experimental setup.
Other studies suggested that none of the mature DENV pro-
teins showed activity as RSSs (32). To investigate whether similar
results could be obtainedwithWNVproteins, we cloned themand
tested for RSS activity in reporter-based plant (Fig. 2C) andmam-
malian (Fig. 2D)RNAi suppressor assays (9, 57). TheWNVcapsid
protein was also cloned and tested, since only a truncated version
(20 amino acids) of capsid is expressed from theWNV replicon in
Fig. 1 (27).
Clearly, none of theWNVnonstructural (NS) proteins nor the
capsid (C) protein could suppress reporter gene silencing in plants
(Fig. 2C) or mammalian cells (Fig. 2D), in contrast to the positive
controls, TSWV-NSs andRHBV-NS3,which are potent RSSs used
in plant andmammalian cells, respectively (57, 58). In both assays,
the expression of WNV NS1, NS3, and NS5 was confirmed by
Western blot analysis (data not shown). There is a possibility that
the expression levels of WNV products were not high enough to
display RSS activity; however, the positive controls in the plant
and mammalian RNAi suppressor assays (TSWV-NSs and
RHBV-NS3, respectively) were produced from the same expres-
sion vectors and worked efficiently (Fig. 2C and D). Overall, these
results suggest that the observed interference of WNV replicon
RNA replication with shRNA-induced RNAi is independent of
WNV-encoded viral proteins.
Noncoding flavivirus RNA of WNV suppresses shRNA-in-
duced silencing inmammalian cells. SinceWNVproteins didnot
suppress RNAi, the question remainedwhichWNVproducts pro-
duced from replicon RNA are able to suppress RNAi? Therefore,
we also tested in our assays a plasmid producing a noncoding
WNV RNA product called sfRNA (52). sfRNA is an abundantly
expressed, 3=UTR-derived RNAmolecule 525 nt in length, with a
complex RNA structure containing many stem-loops (19, 52),
and shares some structural similarity to the RSS of adenovirus VA
RNAI/II (3). A plasmid expressing VA RNA was included in the
mammalian RNAi suppressor assay as an additional positive con-
trol.
In contrast to the result obtained for the WNV nonstructural
proteins, adenovirus VA RNA very efficiently suppressed shRNA-
induced silencing inmammalian cells, with 87% relative luciferase
activity (Fig. 2D). Notably, sfRNA of WNV was also able to sup-
press RNAi, with an efficacy (63% relative luciferase activity)
similar to that of the positive control RHBV-NS3 (64% relative
luciferase activity) but slightly less efficient than VA RNA (Fig.
2D). The remote possibility that the short hepatitis delta virus
FIG 1 WNV RNA replication suppresses shRNA-mediated gene silencing in
mammalian cells. (A) Schematic representation of the puromycin-selectable
WNV replicon, encoding -galactosidase (Bgal) as a reporter. UTR, untrans-
lated region; PAC, puromycin acetyltransferase; NS, nonstructural protein.
(B) WNV replication in Vero cells expressing the WNV replicon (WNVrep)
was verified by -galactosidase detection using X-Gal staining (upper panel).
Wild-type Vero cells were stained as a control (lower panel). (C) Suppression
of shRNA-induced silencing inVeroWNVrep cells (gray) or normal Vero cells
(black). Cells were cotransfected with Firefly luciferase (Fluc), Renilla lucifer-
ase (Rluc), and shRNA, either Fluc-specific (shFluc) or off-target (sh-scram-
bled).Normalized relative luciferase expression (Fluc/Rluc)was determined at
48 hpt, and the means of four independent experiments performed in dupli-
cate are shown with the standard errors. Asterisks indicate significance deter-
mined by an independent two-sample Student t test (P 0.05).
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FIG 2 WNV sfRNA inhibits shRNA-induced silencing in mammalian cells. (A and B) Electromobility gel shift analysis performed by incubating cell lysates of
normal Vero, BHK, Ap61, or Vero WNVrep/DENVrep, BHKWNVrep, Ap61 WNVrep cells with radiolabeled siRNA molecules, ath-miRNA171/miRNA171*
duplex miRNA molecules, or 114-nt radiolabeled dsRNA molecules for 20 min at room temperature. RNA-protein complexes were separated on a native
polyacrylamide gel, dried and exposed overnight to a phosphorimager screen.MBP-NS3 of RHBV, P19 of CymRSV, or influenza virus NS1 were used as positive
controls. (C) WNV NS1-5 does not suppress RNA silencing in plants. Agrobacterium tumefaciens harboring vectors encoding mGFP were coinfiltrated in
Nicotiana benthamiana leaves withMBP (negative control),Tomato spotted wilt virus (TSWV)NSs (positive control), or differentWNVproteins (C107 [capsid],
NS12A, NS2B3, NS4AB, and NS5) constructs, respectively. Green fluorescence under UV light was determined in infiltrated leaves 5 days after agroinfiltration.
(D) Suppressor activity of WNV proteins and sfRNA on shRNA-induced silencing in Vero cells. Luciferase activity of cells cotransfected with Firefly luciferase
(Fluc), Renilla luciferase (Rluc), a specific (shFluc) or off-target (sh-scrambled) shRNA, and different WNV proteins (C107 [capsid], NS12A, NS2B3, NS4AB,
and NS5) or WNV sfRNA (gray bars) was measured at 48 hpt. The NS3 of RHBV and VA RNA were used as positive controls (black bars) and a NS3 mutant
(NS3mRHBV) as negative control (white bar). Themeans of two independent experiments performed in duplicate are shownwith the standard errors. Asterisks
indicate significance byTukey’sHSD (P 0.05). (Inset) Schematic representation of the sfRNA structure. SL, stem-loop;DB, dumbbell; RCS, repeated conserved
sequence; CS, conserved sequence. (E) To determine the lack of putative RNAi suppressor activity by the added HDVr sequence, the experiments performed for
panel Dwere repeated withMBP,MBP-HDVr,WNV-sfRNA, and VARNA. Themeans of two independent experiments performed in duplicate are shownwith
the standard errors. Asterisks indicate significance determined by Tukey’s HSD (P 0.05).
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ribozyme (HDVr) sequence present in WNV replicons and the
WNV sfRNA constructs could suppress RNA silencing was ruled
out by including a plasmid expressing MBP-HDVr as a control,
lacking anyRSS activity (Fig. 2E). Taken together, the results show
that WNV sfRNA is able to suppress shRNA-induced RNAi in
mammalian cells.
WNV sfRNA is processed by human Dicer in vitro and sup-
presses RNAi in a concentration-dependent manner. sfRNA is
abundantly expressed during infections of all flaviviruses in cul-
tured cells of both vertebrate and invertebrate origin (52). WNV
sfRNA represents the last 525 nt of the 3=UTR and is predicted to
contain several stem-loop structures (40, 52) with structural sim-
ilarity to VA RNAI/II and even to pre-miRNA structures, both of
which are known to be processed by Dicer (4). The highly struc-
tured adenovirus VA RNAI/II molecules, expressed at very high
concentrations during adenovirus infection, bind to RNAi pro-
teins and thereby oversaturate and block the natural silencingma-
chinery (3).
To further elucidate the mechanism of sfRNA suppression of
RNAi, we investigated whether sfRNA could interfere in vitrowith
processing of long dsRNA templates by Dicer. A Dicer cleavage
assay with in vitro-transcribed WNV sfRNA, long dsRNA (Dicer
substrate) and recombinant humanDicer was performed (Fig. 3).
As expected, Dicer was able to digest the long dsRNA template,
leading to the production of siRNA (Fig. 3A, bottom arrow).
However, when sfRNA was added to the reaction mixture in in-
creasing concentrations, the in vitro processing of dsRNA into
siRNA was severely inhibited (Fig. 3B). It should be noted that in
addition to the inhibition of Dicer processing of long dsRNA,
sfRNA itself was also processed into smaller cleavage products
(Fig. 3B, arrowheads), suggesting that sfRNA acted as a competing
Dicer substrate in this assay. We were unable to determine the
specific cleavage sites within the sfRNA, but it could be hypothe-
sized that cleavage would most likely occur within the double-
stranded stem-loop structures that are abundantly present in
sfRNA. Whereas these results were obtained in a rather artificial
experimental in vitro setting with a limited number of biological
components (Dicer and RNA), a similar concentration-depen-
dent inhibition of WNV sfRNA on RNAi was also observed in a
FIG 3 sfRNA interferes with Dicer cleavage of dsRNA in vitro and suppresses
RNAi in a concentration-dependent manner. (A and B) dsRNA of 700 bp was
incubated either in the absence (A) or in the presence (B) of decreasing
amounts of in vitro-transcribedWNV sfRNA with human recombinant Dicer
and loaded onto an ethidium bromide-stained agarose gel. (C) Renilla lucifer-
ase (Rluc), Firefly luciferase (Fluc), either specific (shFluc) or off-target
(sh-scrambled) shRNA, and decreasing concentrations of WNV sfRNA were
cotransfected into Vero cells. RHBV NS3 or a dysfunctional mutant (RHBV
NS3m) were used as positive and negative controls, respectively. Relative lu-
ciferase expression (Fluc/Rluc) was determined at 48 hpt and normalized to
the cells transfected with off-target shRNA. The means of two independent
experiments performed in duplicate are shown with the standard errors. As-
terisks indicate significance determined by Tukey’s HSD (P  0.05). (D) By-
passing of sfRNA-mediated RNAi suppression by siRNA transfection. Renilla
luciferase (Rluc), Firefly luciferase (Fluc), either specific (siFluc) or off-target
(si-scrambled) siRNA, and plasmids expressing WNV/DENV sfRNA were
cotransfected into Vero cells. Tombusvirus P19, which binds siRNA, was used
as a positive control. The relative luciferase expression (Fluc/Rluc) was deter-
mined at 48 hp siRNA transfection and normalized to the cells transfectedwith
off-target siRNA. The means of four independent experiments performed in
triplicate are shown with the standard errors. Asterisks indicate significance
determined by Tukey’s HSD (P 0.05).
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shRNA-induced silencing suppressor assay in mammalian cells
(Fig. 3C).
Interference with Dicer processing suggests that sfRNA acts as
RSS upstream of RISC. In this scenario, transfected siRNA should
be capable of bypassing RSS activity, since it is directly loaded into
RISC independent of Dicer. We therefore examined whether or
not sfRNA could suppress siRNA-mediated RNAi. Vero cells were
transfected with luciferase reporter plasmids and with a sfRNA-
expressing plasmid. Next, the cells were transfected with Fluc-
specific siRNA. Fluc activity wasmeasured 48 h after siRNA trans-
fection. The results showed that P19, a strong RSS with high
affinity to siRNA, but not the sfRNAs of WNV and DENV could
suppress siRNA-induced RNAi (Fig. 3D).
Taken together, the results suggest that WNV sfRNA, as was
previously reported for VARNAI/II (3), can interfere in a concen-
tration-dependent manner with Dicer processing of dsRNA in
vitro and of shRNA-induced RNAi pathway in vivo. Bypassing of
this interference with transfected siRNA suggests that the inhibi-
tory effect of sfRNA on RNAi activity is upstream of RISC.
WNV RNA replication interferes with the endogenous
miRNA pathway in mammalian cells. The siRNA pathway in in-
sects and plants has clearly been demonstrated to be involved in
antiviral responses, but the role of the siRNA pathway in an anti-
viral response in mammals is the subject of debate (12). At the
same time, the presence and importance of themiRNApathway in
mammalian gene regulation is well accepted (2). In contrast to
plants and insects, mammals code for only oneDicer enzyme, and
no clear distinction exists between siRNA and miRNA pathways.
Interference of an RSS with mammalian Dicer is therefore ex-
pected to negatively affect RNAi induced by both siRNA and
miRNA molecules.
To investigate whether sfRNA indeedwould also interfere with
the endogenous miRNA pathway in mammalian cells, a previ-
ously described Firefly luciferase-basedmiRNA reporter assaywas
performed using a Fluc sensor construct harboring multiple hu-
manmiRNA-30 (hsa-miR30) target sites in the 3=UTR of the Fluc
mRNA (76). This sensor construct, Fluc-miR30-AP, is silenced by
endogenously produced miR30 in Vero cells. As expected,
cotransfection of the Fluc-miR30-AP sensor construct andRenilla
luciferase as an internal transfection control resulted in decreased
Fluc expression (10% relative luciferase activity) compared to cells
transfected in a similar way with a sensor construct harboring
randomized miRNA target sites (Fig. 4A). However, in Vero-
WNVrep cells, a significant suppression ofmiR30-induced silenc-
ing (26% in comparison to 10% relative luciferase activity in
normal Vero cells) was observed (Fig. 4A). To demonstrate that
theobservedgene silencingviamiR30was truly sequence specific, the
experiment was repeated in a background of overexpression of
the homologous hsa-miR30 and a heterologous hsa-miRNA-21
(miR21). Again, cotransfection of the Fluc-miR30-AP sensor con-
struct in Vero cells, together with a plasmid overexpressing hsa-
miR30 (76), led to silencing (28% relative luciferase activity) of the
Fluc signal. The observed silencing was sequence specific, because in
cells transfectedwith a plasmid expressing hsa-miR21 (76) no silenc-
ing was observed (Fig. 4B). In Vero-WNVrep cells, a significant sup-
pressionofmiR30-induced silencing (82%compared to28%relative
luciferase activity in normal Vero cells) was observed (Fig. 4B). In
conjunction with the experiments shown earlier, the results pre-
sentedheredemonstrate thatWNVRNAreplication suppresses both
siRNA- andmiRNA-induced RNAi inmammalian cells.
RSS activity of sfRNA is not restricted to the 3=SL. In mos-
quito cells, we have recently shown that the 3=SL (Fig. 2D, inset) in
FIG 4 Suppression of the mammalian miRNA pathway inWNV replicon cells. (A) Vero cells either expressing the WNV replicon (Vero-WNV [s]) or lacking
the replicon (Vero wild type []) were transfected with expression vectors encoding pCMV-luc-miR30-AP or pCMV-luc-random alone or in combination with
either a specificmiRNA (hsa-miRNA30) or off-target (hsa-miRNA21). The results shown are themeans of two independent experiments performed in duplicate.
Asterisks indicate significance determined by independent two-sample Student t tests (P 0.05). (B) The luciferase expression was measured 2 days posttrans-
fection, and the relative luciferase expression (Fluc/Rluc)was determined. The luciferase levelmeasuredwith nonspecific has-miRNA21was set at 1.0. The results
shown are representative of three independent experiments performed in duplicate. Asterisks indicate significance determined by an independent two-sample
Student t test (P 0.05).
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the 3=UTR (and thus sfRNA) of WNV is a precursor for a viral
miRNA (25) capable of silencing a miRNA reporter construct. To
obtain further insight into the mechanism of sfRNA-mediated
RNAi suppression, we asked the question whether putative
miRNA production from the sfRNA 3=SL was correlated with the
observed Dicer inhibition and RSS activity in both mammalian
and insect cells. The miRNA reporter plasmids contain a CMV
promoter for expression inmammalian cells (Fig. 5A) and encode
a Fluc gene with a 3=UTR containing 3=SL-derived miRNA target
sequences called A1A2rc and C1C2rc, which are reverse comple-
mented to the sequences in the 3=SL (Fig. 5B). First, to verify the
functionality of the pGL3-based miRNA sensor constructs, they
were cotransfected with pSuper plasmids expressing siRNA spe-
cifically targeting either side of the 3=SL (A1A2 orC1C2) (Fig. 5C).
This experiment indicated that the A1A2 andC1C2 repeat regions
cloned in both orientations in pGL3 in the 3=UTR of Fluc were
efficiently targeted (	90% silencing of Fluc) by complementary
siRNAgenerated frompSuper plasmids, indicating that the sensor
constructs were functional. Next, sfRNA was cotransfected along
with the miRNA reporter plasmids (Fig. 5D). The result showed
that neither the A1A2rc nor the C1C2rc reporter transcript was
significantly silenced in the presence of sfRNA. This results sug-
gests that sfRNA is unlikely to be a source of 3=SL-derivedmiRNA
in mammalian cells in contrast to insect cells (25).
Since no viral miRNA derived from the 3=SL could be identi-
fied in the miRNA sensor assay, we sought to determine whether
other RNA structures within sfRNA could contribute to the ob-
served RSS activity. A number of deletions (from SL-II to CS3,
from SL-II to CS1, and 3=SL only) (52) were introduced in sfRNA
(Fig. 5E), and plasmids expressing the truncated sfRNA variants
were tested in an RNAi suppressor assay as before (Fig. 5F). The
results indicated that all sfRNA variants still displayed RSS ac-
tivity, including the relatively short variant consisting of only
the CS1 and 3=SL RNA structures. This result suggested that
more than a single RNA structure within sfRNA was involved
in RSS activity.
sfRNA suppresses short hairpin RNA-induced silencing in
insect cells. Like many other arboviruses, WNV is transmitted by
mosquitoes, actively replicates inmosquito tissues, and eventually
accumulates in the salivary glands prior to virus transmission to
the vertebrate host via blood-feeding. A characteristic of most
arbovirus infections is the limited pathology in the infected insect
and the establishment of persistent virus replication (17). RNAi is
implicated to be a determining factor for successful arbovirus in-
FIG5 Mapping of RNAi suppressor activity withinWNV sfRNA. (A toD) 3=SL-derivedmiRNA sensor assay using Firefly luciferase-based sensor constructs. (A)
Schematic representation of miRNA sensor constructs for expression in mammalian cells. Reverse complement (rc) of A1A2 and C1C2 tandem repeats are
indicated in black and gray, respectively. Sequences used for shRNA cloning into pSuper plasmids are indicated in boldface. Fluc, Firely luciferase; SV40, simian
virus 40 promoter; pA, polyadenylation signal; Xb, XbaI restriction site; Xh, XhoI restriction site. (B) Schematic representation of theWNV3=SL. A1A2 andC1C2
sequences for tandem repeat cloning into miRNA sensor constructs are indicated in black and gray, respectively. (C) Functionality of miRNA sensor constructs.
Cells were cotransfectedwith pRL-TK, pGL3-(sensor constructs), and either pSuper-A1A2 or pSuper-C1C2or control plasmid. The relative luciferase expression
(Firefly/Renilla) was determined at 24 hpt. The means of two independent experiments performed in triplicate are shown with the standard errors. Significance
was tested by an independent two-sample Student t test (P  0.05). (D) Silencing of miRNA sensor constructs by sfRNA expression in Vero cells. Cells were
cotransfected with pRL-TK, pGL3-(sensor constructs), and either pDEST40-sfRNA or control plasmid. The relative luciferase expression (Firefly/Renilla) was
determined at 24 hpt. The means of three independent experiments performed in duplicate are shown with the standard errors. Significance was tested by an
independent two-sample Student t test (P  0.05). (E) Schematic representation of WNV sfRNA with abbreviations as in Fig. 2. The numbers are nucleotide
positions from the 3= terminus of theWNV3=UTR.Deletionswithin sfRNAare indicated. (F) Suppressor activity ofWNVsfRNA truncations on shRNA-induced
silencing in Vero cells. The luciferase activity of cells cotransfected with Firefly luciferase (Fluc), Renilla luciferase (Rluc), a specific (shFluc) or off-target
(sh-scrambled) shRNA, and WNV sfRNA variants was measured at 48 hpt. The NS3 of RHBV was used as a positive control, and MBP was used as a negative
control. The means of two independent experiments performed in duplicate are shown with the standard errors. Asterisks indicate significance determined by
Tukey’s HSD (P 0.05).
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fection of the mosquito (6). It has been shown that heterologous
RSS, e.g., FHV-B2, can enhance alphavirus replication inmosqui-
toes (11). To determine whether sfRNA could have a similar effect
on alphavirus replication, we engineered sfRNA into a Semliki
Forest virus (SFV) replicon anddetermined the level of replication
in RNAi-competent U4.4 cells. As a control, we included a SFV
replicon expressing another, unrelated, highly structured RNA
derived from the encephalomyocarditis virus (EMCV) internal
ribosome entry site (IRES) (Fig. 6A). Both replicons expressed
Renilla luciferase (Rluc) from the nonstructural polyprotein as
described previously (28). The results show that SFV replication in
mosquito cells is enhanced upon coexpression in cis of sfRNA
(Fig. 6B).
To determine the effect ofWNV sfRNA on the siRNA pathway
in insect cells, a dsRNA-mediated silencing assay using luciferase
reporters was developed for mosquito cells to allow easy quantifi-
cation. To this end, Aedes albopictusU4.4 cells were cotransfected
with plasmids encoding Fluc, Rluc (internal transfection control)
and either MBP orWNV sfRNA. At 24 hpt, silencing was induced
by transfection of dsRNA, either specifically against Firefly lucif-
erase (dsFluc) or off-target (ds-scrambled), and the luciferase ac-
tivity was determined at 48 hpt. Cells cotransfected with MBP,
Fluc, and dsFluc carrying plasmids showed silencing of Fluc ex-
pression (ca. 47% relative luciferase activity), which was not ob-
served with ds-scrambled (Fig. 6C). In the case of cotransfection
of WNV-sfRNA with Fluc and dsFluc, no significant reduction of
Fluc activity could be detected, indicating that sfRNA very effi-
ciently suppressed dsRNA-induced silencing (Fig. 6C).
To ensure that the observed effect of sfRNA was not an
anomaly of dsRNA-induced silencing in mosquito U4.4 cells, a
similar experiment was performed in Drosophila melanogaster
S2 cells, using a shRNA-mediated silencing assay. In this exper-
iment, S2 cells were cotransfected with inducible plasmids en-
coding Fluc, Rluc (internal control), and shRNA constructs
specifically targeting Fluc (shFluc) or a control shRNA target-
ing GFP (shGFP). Next, Fluc, Rluc, and shRNA expression was
induced by the addition of CuSO4 to the medium at 24 hpt, and
the Fluc activity was measured at 48 hpt and normalized to the
Rluc readings (Fig. 6D). Cells cotransfected with MBP, Fluc,
and shFluc plasmids showed silencing of Fluc expression (ca.
55% relative luciferase activity), which was not observed with
the shGFP-negative control (Fig. 6D).When a plasmid express-
ing WNV sfRNA was cotransfected with Fluc and shFluc, how-
ever, Fluc silencing was suppressed with am efficiency similar
to that of the positive control RHBV-NS3 (Fig. 6D) (24), with
81 and 83% relative luciferase activities, respectively. Similar to
what was observed in mammalian cells, the RSS activity of
WNV sfRNA was concentration dependent (Fig. 6D). In con-
clusion, these experiments show that WNV sfRNA is able to
interfere with the siRNA-based pathway in insect cells.
sfRNA suppresses the induced miRNA pathway in insect
cells. In addition to the antiviral siRNA pathway, insects also have
a functional miRNA pathway that has a function in gene regula-
tion similar to that seen, for example, in mammals. In contrast to
mammals, however, insects have two distinct Dicer enzymes,
Dcr-1 and Dcr-2, instead of one, with dedicated functions in the
miRNA or siRNA pathway, respectively (1). Although no clear
antiviral activity has been attributed to the miRNA pathway in
insects, the question remained as to whether WNV sfRNA, apart
from its activity in inhibiting the siRNA pathway, could also in-
terfere with the miRNA pathway in insect cells. Several viral RSS
proteins have been demonstrated to be able to interfere with both
the siRNA and the miRNA pathways in different organisms
(14, 58).
D. melanogaster S2 cells were cotransfected with an inducible
Fluc dme-miRNA1-sensor construct (Fluc-3=UTR), vectors en-
coding either specific dme-miRNA1 or off-target dme-miRNA12,
Rluc (internal transfection control), and either WNV sfRNA,
MBP (negative control), or Carnation Italian ringspot virus
(CIRV) P19 (positive control). As expected, a decrease in Fluc
expression (ca. 48% relative luciferase activity) was observed in
cells cotransfectedwithMBP, Fluc-3=UTR, and dme-miRNA1but
not with the off-target dme-miRNA12 (Fig. 7A). To make sure
that the observed Fluc silencing was the result of miRNA1 and
thus independent of the siRNA pathway, we checked that the
miRNA1-induced silencing was lost in cells treated prior to trans-
fectionwith dsRNA specifically targetingAgo1 but notAgo2 or the
nonspecific GFP (Fig. 7B). Successful depletion of Ago1 and Ago2
transcripts and proteins was checked by RT-PCR and Western
blotting, respectively (Fig. 7C). SinceAgo1 andAgo2 are known to
be predominantly loaded with miRNA and siRNA, respectively,
these results confirmed that the miRNA pathway in insect cells
was capable of silencing the Fluc reporter construct harboring
dme-miRNA1 target sites.
After the demonstration of sequence-specific silencing by
miRNA1 through the miRNA pathway, the putative suppressor
effect of WNV sfRNA was investigated. A significant and repro-
ducible rescue of Fluc expression was observed in the presence of
WNV sfRNA, to a level similar to that observed for CIRVP19 (Fig.
7A), suggesting that WNV sfRNA interferes with the miRNA
pathway in insect cells. Collectively, these results demonstrate that
WNV sfRNA interferes with both the siRNA- and the miRNA-
based pathways in insect cells.
DENV also displays RSS activity in mammalian and insect
cells. sfRNA is produced by all flaviviruses (52, 60). To determine
whether the observed interference with the RNA silencing path-
ways is common among flaviviruses, the same experiments were
conducted with DENV1.
First, Vero cells stably expressing a DENV1 replicon (Vero-
DENVrep) were established by transfection of Vero cells with
DENV1 replicon RNA harboring an IRESneo cassette (54). Stable
replicon cells were selected with G418. Active DENV replicon
RNAreplicationwas confirmedby immunofluorescence using the
J2 anti-dsRNA antibody (Fig. 8A). Vero-DENVrep cells showed
less silencing (ca. 28% relative luciferase activity) if transfected
with shRNA specific against Firefly luciferase in comparison to
wild-type Vero cells (10% relative luciferase activity) (Fig. 8B).
DENV sfRNA was also tested in the shRNA-mediated si-
lencing assays in mammalian (Vero) and RNAi-competent
mosquito (U4.4) cells and displayed a similar RSS activity (Fig.
8C and D) compared to WNV sfRNA (Fig. 2D and E and Fig.
8C). Furthermore, no RNAi suppressor activity of DENV1
nonstructural proteins was detected in the plant suppressor
assay (data not shown), and no retardation of either small or
long dsRNA was observed in DENV replicon cell extracts (Fig.
2A). These results show that the ability of sfRNA to interfere
with the RNA silencing is observed for both WNV and DENV,
in mammalian as well as in insect cells.
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DISCUSSION
RNA silencing is known as an important antiviral response in
insects and plants. Until now, all investigated plant and “true”
insect viruses have been shown to encode RSS proteins, which are
essential for the establishment of a successful viral infection. Our
results and those of others (32) show that no proteins with RSS
activity have thus far been identified in flaviviruses, despite the fact
that these viruses are successfully infecting their mosquito vector.
FIG6 WNVsfRNAinterfereswith siRNA-induced silencing in insect cells. (A)Schematic representationof SFVconstructs.TheRenilla luciferase (Rluc) gene is inserted
upstream of nsP4. sfRNA or the EMCV IRES sequence is inserted downstream of the 26S subgenomic promoter. Schematic RNA structures of sfRNA and the EMCV
IRES are shown. (B)Capped, in vitro-transcribed SFVRNAwas transfected inAedes albopictusU4.4mosquito cells. Rluc expressionwasmeasured at 24 hpt. Themeans
of four independent experiments performed in duplicate are shown with the standard errors. Asterisks indicate significance determined by independent two-sample
Student t test (P 0.05). (C)Aedes albopictusU4.4mosquito cells were cotransfected with Firefly luciferase (Fluc),Renilla luciferase (Rluc), andMBP orWNV sfRNA
constructs.After 24h, silencingwas inducedby transfectionof either specific (dsFluc)oroff-target (ds-scrambled) in vitro-transcribeddsRNA.The luciferase activitywas
measured at 48 hpt, and the normalized relative luciferase activity (Fluc/Rluc) is shownwith the standard errors (means of two independent experiments performed in
duplicate). Asterisks indicate significance determined by Tukey’s HSD (P 0.05). (D) Concentration-dependent effect of sfRNA on shRNA-induced silencing deter-
mined inD. melanogaster S2 cells by transfection of decreasing concentrations ofWNV-sfRNA (140, 50, and 20 ng) construct in concert with Firefly luciferase (Fluc),
Renilla luciferase (Rluc), and either specific (shFluc) or off-target (sh-scrambled) shRNA.RHBVNS3wasused as a positive control. The luciferase activitywasmeasured
at 48hpt, and thenormalized relative luciferase activity (Fluc/Rluc) is shownwith the standard errors (meansof three independent experiments performed induplicate).
Asterisks indicate significance determined by Tukey’s HSD (P 0.05).
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The RNA silencing pathway is the major antiviral response in
mosquitoes against flavivirus infection (6), and the knockdown of
this pathway results in an increase of viral replication in mosqui-
toes (55). It has remained unclear to what extent and how flavivi-
ruses tweak this antiviral RNAi response for its own benefit. In the
present study we now show that a noncoding, 3=UTR-derived vi-
ral RNA produced by the flaviviruses WNV and DENV displays
RNAi suppressor activity in both insect and mammalian cells.
This noncoding viral RNA is present in the 3=UTR of all flavi-
virus genomes and, interestingly, is also abundantly produced as
an XRN1-exonuclease-resistant molecule in flavivirus-infected
cells of both insect andmammalian origin (52). This predominant
noncoding RNAmolecule was previously named subgenomic fla-
vivirus RNA (sfRNA) and is completely identical to the 3=UTR
with the exception that it misses the first100 nt (52). The flavi-
virus 3=UTR and hence also sfRNA share some structural similar-
ities with the adenovirus VA RNAI/II molecules, which have been
shown to act as efficient RSS inmammalian cells (3). Previously, it
was shown that sfRNA is important for virus-induced cytopathic
and pathogenicity inmammals (52), andmore recent studies sug-
gested the inhibition of the host innate immune response as one of
the potential mechanism of its action (59). Our present work sug-
gests another potential mechanism for the sfRNA, i.e., as nucleic
acid-based RSS both in both mammalian and in insect cells.
We have carried outmost of the experiments with the plasmids
expressing a truncated 3=UTR corresponding to the size of sfRNA
(525 nt). Therefore, we cannot conclude at this stage whether or
not the entire 3=UTR present in (the context of) the viral genome
has the same RSS activity as sfRNA. Based on studies on genome
cyclization during flavivirus infection, which show that the 3=UTR
is base paired to the 5=UTR (26, 29, 67), the genomic viral 3=UTR
may be far less accessible to RNAi factors compared to the abun-
dantly produced sfRNA. The flaviviral genomic RNA replication
is localized within endoplasmic reticulum membrane-enclosed
vesicle packets (39, 73), whereas sfRNA is localized in cytoplasmic
processing bodies (52), structures that are enriched in RNAi fac-
tors (16, 49). This suggests that sfRNA is more likely to interfere
with RNAi than the 3=UTR of genomic viral RNA. Mutations in
the 3=UTR leading to reduced expression of sfRNA (19, 52) also
modify the secondary structure and likely function of sfRNA. This
makes it difficult to discriminate whether the 3=UTR itself or the
sfRNA,which is derived from it, displays the observed RSS activity
in cells with active WNV replication.
Results from in vitro Dicer cleavage experiment suggest that
WNV sfRNAmay act as an RSS by substrate competition (Fig. 3),
thereby possibly oversaturating Dicer in a concentration-depen-
dent manner. Although this experiment is highly artificial and
largely ignores the complexity of factors present in a flavivirus-
FIG 7 WNV sfRNA interferes with Ago1-dependentmiRNA-induced silencing in insect cells. (A) Suppression of dme-miRNA1-induced silencing in S2 cells by
cotransfection of a pMT-Renilla luciferase (Rluc), pMT-Firefly luciferase (Fluc)-dme-miRNA1 sensor construct, either specific (dme-miRNA1) or off-target
(dme-miRNA12) primary miRNA and either MBP, CIRV P19 (as a positive control), or WNV sfRNA (180 or 50 ng). After induction at 48 hpt, the relative
luciferase expression (Firefly/Renilla) was determined at 72 hpt, and themeans of three independent experiments in duplicate are shownwith the standard errors.
Asterisks indicate significance by Tukey’s HSD (P 0.05). (B) Silencing of the pMT-Firefly luciferase (Fluc)-dme-miRNA1 sensor construct is Ago1 dependent.
S2 cells were soaked with 200 ng of dsRNA either Ago1, Ago2, or EGFP (unspecific) during seeding. dme-miRNA1-induced silencing was induced by cotrans-
fection of pMT-Renilla luciferase (Rluc), pMT-Firefly luciferase (Fluc)-dme-miRNA1 sensor construct, either specific (dme-miRNA1) or off-target (dme-
miRNA12) primary miRNA. The means of three independent experiments in duplicate are shown with the standard errors. Asterisks indicate significance
determined by an independent two-sample Student t test (P 0.05). (C) Confirmation of successful Ago1/2 depletion in S2 cells. To check the knockdown level
of Ago1/2, RT-PCR was carried out on total RNA purified from dsRNA-silenced cells. Western blot analysis of Drosophila melanogaster Ago1/2 was performed
to confirm successful depletion of Ago1/2 in S2 cells.
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infected cell, the proposedRNAdecoymechanism is supported by
the observed concentration-dependent RNAi suppressor activity
of sfRNA in shRNA-mediated silencing experiments (Fig. 3C and
6D), as well as the ability to bypass the RSS activity of sfRNA by
transfection with siRNA (Fig. 3D). Nucleic acid-based decoy
mechanisms in other viral systems have recently been published
for SFV (61) and Cauliflower mosaic virus (CaMV) (7). In SFV
infection, hot spot-derived viral siRNAs have been found to be
rather inefficient in silencing of viral genomic RNA, thus allowing
viral replication while saturating RNAi factors (61). During
CaMV infection, high concentrations of RNA produced from a
viral noncoding region are subsequently processed into siRNAs
and incorporated into RISC to presumably act as a decoy (7).
Although CaMV already encodes a RSS protein that interferes
with the RNA-dependent RNA polymerase-mediated amplifica-
tion of siRNA, the virus may in this case, paradoxically, benefit
from the massive production of siRNAs derived from its noncod-
ing RNA as backup strategy. Thus, abundant production of non-
coding or viral siRNA can be advantageous for viral infection.
Although sfRNA itself may not lead to massive production of
decoy viral siRNA, its strong secondary structure (19, 45, 52) may
decrease overall Dicer activity or render the genomic viral RNA
inaccessible for an activated RISC. The suggested RNA decoy
mechanism by sfRNA probably results in a lower RSS activity
compared to that of most of the known proteinaceous RSS of true
insect viruses but may still allow sufficient levels of flaviviral rep-
lication needed for successful virus transmission by the vector
mosquitoes. Recent research has shown that the expression of
protein RSS (derived from true insect viruses) by alphaviruses
leads to the rapid death of infectedmosquitoes (11, 43). Similarly,
we now show that expression in cis of sfRNA also enhances SFV
replication in RNAi-competent mosquito cells (Fig. 6B). In light
of these results, it is clear that a delicate balance exists between
arbovirus replication and vector survival. Although all arboviruses
for which this has been analyzed induce RNAi responses, it now
appears that inhibition or evasion does take place (61), and it is
likely that the scale of inhibition or evasion is a key factor. Our
present results do not allow us to directly compare RNAi suppres-
sor activity of sfRNA to that of the protein RSS, but future work
will focus on addressing this important question. It is worth not-
ing, however, that the level of sfRNA produced from plasmid
DNA transfection in most of our RNAi suppressor assays is lower
than the sfRNA level produced in virus-infected or replicon-
transfected cells (52).
Despite the fact that all flaviviruses produce sfRNA (52) and
thusmight suppress RNAi, flavivirus replication can still be inhib-
ited by endogenous miRNA when miRNA target sites are artifi-
cially engineered in the viral RNA (23, 30, 51). This suggests that
sfRNA does not fully block RNAi, which is in agreement with
the lower RSS activity of sfRNA in comparison to, for example,
VA RNA.
In addition to the RSS activity of sfRNA on the antiviral siRNA
pathway in insect cells, we observed similar suppressor activity of
sfRNA on the insect miRNA pathway. In line with this result,
others have recently shown thatWNV infection of Culexmosqui-
toes alters the expression levels of a subset of hostmiRNAs (62). In
FIG 8 Suppression of RNA silencing in mammalian and mosquito cells by DENV sfRNA. (A) Viral RNA replication in Vero cells stably expressing the DENV1
replicon was verified by immunofluorescence using a primary J2 anti-dsRNA antibody and a corresponding rhodamine-labeled secondary antibody (upper
panel). Wild-type Vero cells were stained as a control (lower panel). (B) The effect of DENV RNA replication on shRNA-induced silencing was investigated in
normal Vero cells (black) and in Vero cells stably expressing the DENV replicon (gray). The cells were cotransfected with Firefly luciferase (Fluc), Renilla
luciferase (Rluc), and shRNA, either Fluc-specific (shFluc) or off-target (sh-scrambled). The normalized relative luciferase expression (Fluc/Rluc) was deter-
mined at 48 hpt. The means of three independent experiments performed in duplicate are shown with the standard errors. Asterisks indicate significance
determined by an independent two-sample Student t test (P  0.05). (C) RNA silencing suppression by the DENV sfRNA was investigated in Vero cells by
cotransfection of pFluc, Rluc, either specific (shFluc) or off-target (sh-scrambled) shRNA, and expression constructs of MBP, MBP-HDVr, DENV, sfRNA, or
adenoviral VA RNA. The luciferase expression was measured at 48 hpt. The means of two independent experiments performed in duplicate are shown with the
standard errors. Asterisks indicate significance by Tukey’s HSD (P 0.05). (D) Effect of DENV sfRNA was determined by cotransfection of Aedes albopictus-
derived U4.4 cells with Firefly luciferase (Fluc), Renilla luciferase (Rluc) and MBP, DENV sfRNA, or WNV sfRNA (as positive control) constructs. After 24 h,
silencing was induced by transfection of either specific (dsFluc) or off-target (ds-scrambled) in vitro-transcribed dsRNA. The luciferase activity was determined
48 h after primary transfection and normalized to the cells transfected with off-target dsRNA. The means of three independent experiments performed in
duplicate are shown with the standard errors. Asterisks indicate significance determined by Tukey’s HSD (P 0.05).
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contrast, Aedes albopictusC7/10mosquito cells harboring aWNV
replicon did not display these changes in endogenous miRNA ex-
pression (62). However, the relative levels of viral RNA replica-
tion, which normally correlate with sfRNA expression levels, of
persistent WNV replicon in C7/10 versus virus infection of Culex
mosquitoes was not shown. It remains therefore possible that
sfRNA levels in C7/10 were too low to observe an effect on the
miRNA profile or that defects in RNAi factors in C7/10 cells (42)
play a determining role.
Dual activity of RSS proteins on siRNA- and miRNA-related
pathways has been observed previously for plant-infecting viruses
such as Tomato spotted wilt virus (58) and tombusvirus (66), as
well as the adenoviral VA RNA (38), but their functional impor-
tance during viral replication is still unclear. In insects no such
mechanisms have been reported yet, but some results suggest the
importance of other antiviral responses in addition to the siRNA
pathway. For example, a negative effect on viral replication of
WNV lacking sfRNA has been observed in Dicer-2-deficient
C6/36 mosquito cells (52). This could due to the activity of
Dicer-1 (miRNA-related) or a Dicer-independent RNA silencing
pathway involving piRNAs (42, 68) or to another antiviral re-
sponse independent of RNAi (17).
Herpes-, adeno-, baculo-, and ascoviruses produce virus-en-
coded miRNAs targeting either viral RNA or host genes involved
in cell proliferation, DNA repair, and RNA regulation (5, 20).
Adenoviral VA RNAs are processed by Dicer to viral miRNAs that
are loaded into Argonaute, which can result in its saturation. In
light of the similarities between the secondary structures of ade-
novirus VA RNA and theWNV sfRNA, it may be possible that the
interaction of sfRNA with the miRNA pathway is related to the
processing of a virus-encoded miRNA. Indeed, sfRNA was re-
cently shown to be the main source of 3=SL-derived viral miRNA
in WNV-infected insect cells (25). It is therefore possible that the
functionality of sfRNA as Dicer substrate may determine its RSS
activity, but our results with miRNA sensors show that this viral
miRNA is not (efficiently) produced in mammalian cells (Fig.
5D). In addition, sfRNA variant lacking the 3=SL still did display
some RSS activity (Fig. 5F), suggesting that production of 3=SL-
derived viral miRNA is likely not required for sfRNA to interfere
with the RNAi machinery. Thus, despite the similarities with VA
RNA, which is very efficiently loaded into RISC as viral miRNA
(75), sfRNA displays RSS activity in the cytoplasm without being
fully processed. To fully understand the biological importance of
RNAi suppression by sfRNA in mammalian cells, more elaborate
studies (e.g., on the effect of the depletion of Dicer or other RNAi
components) on flavivirus replication would be needed.
There is some evidence that might suggest the involvement of
miRNA in antiviral RNAi in mammalian cells (for a review, see
reference 47) and possible links between the miRNA pathway and
the IFN response (50, 74). A dual function of a viral product in
both of these pathways has been reported for adenovirusVARNA,
which is able to interact with both the IFN response and the RNAi
in mammalian cells. We previously reported that sfRNA was re-
quired for virus-induced pathogenicity in mammals and hypoth-
esized a putative function in the antiviral IFN pathway (52). In-
deed, recent data show that sfRNA contributes to viral evasion of
the type I IFN-mediated antiviral response (59). It is therefore
tempting to speculate that the observed effects of sfRNA on the
RNAi pathways and on modulation of the IFN response in mam-
malian cells are linked, although further studies are required to
support this supposition.
In conclusion, our findings show that sfRNAs of WNV and
DENV can interfere with two distinct arms of the RNAi path-
way—siRNA andmiRNAmediated—in both insect andmamma-
lian cells. Future experiments will elucidate whether this novel
sfRNA function holds for all flaviviruses and will hopefully reveal
the complete picture describing the different functional roles of
flavivirus noncoding RNA in the innate immune responses of
mosquitoes and vertebrate hosts.
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